Stock comparison
Pro Medicus Limited
PME.AX$18.81BHealthcare Market cap, Sector
Veracyte
VCYT$4.75BHealthcare Market cap, Sector
Overall winner
Pro Medicus Limited
PME.AX 70 VCYT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
PME.AX7wins
0winsVCYT
78B
D46
90A
D57
98A
C61
100A
C68
84B
D46
91A
D47
96A
D52
Side-by-side metrics
| Metric | PME.AX | VCYT |
|---|---|---|
| Market cap | Winner: $18.81B | $4.75B |
| P/E (TTM) | 147.6x | 34.8x Winner |
| EV/EBIT | 106.8x | 38.4x Winner |
| ROIC (TTM) | Winner: 42.56% | 4.73% |
| Gross margin | Winner: 99.85% | 71.31% |
| Net margin | Winner: 54.12% | 16.25% |
| Revenue CAGR 5y | Winner: 31.61% | 23.89% |
| EPS CAGR 5y | 37.34% | - |
| Debt / Equity | Winner: 0.0x | 0.0x |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
PME.AX leads on
- ROIC (TTM)42.56%vs 4.73%+89%
- Market cap$18.81Bvs $4.75B+75%
- Debt / Equity0.0xvs 0.0x+70%
- Net margin54.12%vs 16.25%+70%
VCYT leads on
- P/E (TTM)34.8xvs 147.6x+76%
- EV/EBIT38.4xvs 106.8x+64%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.